Dr. Red­dy's to buy Mayne Phar­ma’s US gener­ics drug list for at least $90M

Gener­ic drugs gi­ant Dr. Red­dy’s Lab­o­ra­to­ries has made a deal to ac­quire Mayne Phar­ma’s US gener­ics port­fo­lio for at least $90 mil­lion.

Mayne Phar­ma sells about 45 dif­fer­ent gener­ics prod­ucts in the US, Dr. Red­dy’s said in a re­lease an­nounc­ing the sale, in­clud­ing gener­ics in women’s health.

Mayne has been work­ing to re­vamp its port­fo­lio and to sup­port the launch of Nextstel­lis, a brand-name birth con­trol pill. In Au­gust of last year, the com­pa­ny said that the Covid-19 pan­dem­ic had left be­hind its goals for the Nextstel­lis launch. The gener­ics busi­ness has been in de­cline, echo­ing strug­gles the in­dus­try has faced across com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER